Manufacturing and Production

Showing 15 posts of 5813 posts found.

Brain implant can lift severe depression, study finds

October 5, 2021 Manufacturing and Production, Research and Development

Researchers from the University of California have created an electrical implant that sits in the skull, wired to the brain, …

NICE recommends first new sickle cell disease treatment in 20 years

October 5, 2021 Manufacturing and Production, Medical Communications, Research and Development

NICE has announced on Tuesday that for the first time in 20 years, a new treatment will be made available …

Debunking vaccine myths and growing concerns

September 28, 2021 Manufacturing and Production

Before the COVID-19 pandemic, vaccines were never seen as a quick fix. Preventative vaccines for Ebola, malaria, and the Zika …
virocell_1_1

ViroCell Biologics announces pivotal partnership with Great Ormond Street

September 28, 2021 Manufacturing and Production

Innovation-driven viral vector manufacturer, ViroCell Biologics, and Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), have announced a …
an

Breakthrough drug approved for Crohn’s disease patients in Japan

September 28, 2021 Manufacturing and Production

Takeda has received approval to manufacture and market Alofisel® (darvadstrocel) in Japan. This drug will be used for the treatment …

MSD discussing acquisition of Acceleron Pharma for $11 billion

September 28, 2021 Manufacturing and Production

Leading science and technology company, Merck (known as MSD outside the US), is in advanced stages of acquiring Acceleron Pharma …

Eisai launch bid for accelerated FDA approval for new Alzheimer’s drug

September 28, 2021 Manufacturing and Production, Medical Communications, Research and Development

Japanese drug maker Eisai has launched a bid for accelerated FDA approval for its new experimental drug for early Alzheimer’s …
sanofi_hq__boetie_hall_web

Sanofi drops mRNA COVID vaccine candidate amid success of rivals

September 28, 2021 Manufacturing and Production, Medical Communications

French healthcare group Sanofi has announced that it is dropping plans for its mRNA COVID vaccine due to the success …

FDA: Accelerated approval for Genmab and Seagen’s TIVDAK

September 21, 2021 Manufacturing and Production, Research and Development

The FDA has granted accelerated approval for Genmab and Seagen’s TIVDAK (tisotumab vedotin-tftv), the first and only approved antibody-drug conjugate …
az

AstraZeneca to invest $340 million on Irish site

September 21, 2021 Manufacturing and Production

AstraZeneca has announced on Tuesday a $340 million plan to establish an active pharmaceutical ingredient (API) manufacturing facility for small …

Vectura removed from DDL Conference amid PMI deal

September 21, 2021 Manufacturing and Production DDL, inhalers, pmi, vectura

 Inhaler and medical device maker Vectura has been removed from pharma conferences Formulation and Delivery UK and Drug Delivery to …

Sajid Javid: Valneva COVID vaccine would not have been approved by MHRA

September 15, 2021 Manufacturing and Production, Medical Communications, Research and Development

On Monday the UK cancelled a deal with French vaccine maker Valneva worth up to €1.4 billion, and Health Secretary …
nhs_sign

NHS in Scotland makes rheumatoid arthritis drug available

September 14, 2021 Manufacturing and Production Galapagos UK, NHS, Scotland, filgotinib, rheumatoid arthritis

The Scottish Medicines Consortium (SMC) have recommended the use of Galapagos UK’s JYSELECA® (filgotinib) for eligible patients with severe active …

Wider use of SGLT2 inhibitors for CVD recommended by NICE

September 7, 2021 Manufacturing and Production, Medical Communications

NICE has updated its guidelines on the management of type 2 diabetes, recommending wider use of SGLT2 inhibitors in those …

Latest content